| 產(chǎn)品名稱 |
Human rhinovirus 1A |
| 商品貨號(hào) |
B196005 |
| Classification |
Picornaviridae, Enterovirus, Rhinovirus A |
| Deposited As |
Rhinovirus 1a |
| Agent |
Human rhinovirus 1A |
| Strain |
2060 |
| Common Name |
Human rhinovirus 1A |
| Applications |
Respiratory research |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format |
frozen 1.0 mL |
| Storage Conditions |
-70°C or colder |
| Images |
 |
| Comments |
VR-1559™ was created by solvent treating Mycoplasma positive VR-1364™, passaging it three times and finding no detectable Mycoplasma by PCR. VR-1364™ was derived by replenishment (passage) of NIAID reagent V-101-003-021 (VR-1110™) at the ATCC. |
| Effect on Host |
CPE, cell rounding and sloughing |
| Recommended Host |
H1 HeLa (ATCC® CRL-1958™)
|
| Growth Conditions |
Temperature: 33°C
Recommendations for Infection: For best results, infection should be performed on a 80-90% confluent, 18-48 hour old cellular monolayer. Prepare dilution of virus in minimum amount of volume (e.g. 1 mL per 25 cm2). Wash monolayer with PBS or serum free medium prior to inoculation. Adsorb virus dilution for 1-2 hours at 37°C in a humidified 5% CO2 atmosphere, rocking every 20-30 minutes to redistribute inoculum. End adsorption by adding virus growth medium.
Incubation: 1-4 days at 33°C in a humidified 5% CO2 atmosphere, until CPE is progressed through 80% of the monolayer. |
| Name of Depositor |
ATCC, NIAID |
| Special Collection |
NCRR Contract |
| Source |
Naso-pharyngeal washings from patient with mild respiratory illness, Ohio. |
| References |
Mogabgab WJ, Pelon W. Problems in characterizing and identifying an apparently new virus found in association with mild respiratory disease in recuits. Ann NY Acad Sci 67(8): 403-412, 1957. PubMed: 13411976
Pelon W, et al. A cytopathic agent isolated from naval recruits with mild respiratory illnesses. Proc. Soc. Exp. Biol. Med. 94(2): 262-267, 1957. PubMed: 13408229
Pelon, W. Further studies on 2060 virus. Proc. Soc. Exp. Biol. Med. 102: 392-395, 1959. PubMed: 14431507
Pelon W. Classification of the "2060" virus as Echo 28 and further study of its properties. Am. J. Hyg. 73: 36-54, 1961. PubMed: 13734022
|
| Cross References |
Nucleotide (GenBank) :
FJ445111.1
Human rhinovirus 1 strain ATCC VR-1559, complete genome
|